1. Home
  2. CGEM vs BELFB Comparison

CGEM vs BELFB Comparison

Compare CGEM & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • BELFB
  • Stock Information
  • Founded
  • CGEM 2016
  • BELFB 1949
  • Country
  • CGEM United States
  • BELFB United States
  • Employees
  • CGEM N/A
  • BELFB N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • BELFB
  • Sector
  • CGEM Health Care
  • BELFB
  • Exchange
  • CGEM Nasdaq
  • BELFB Nasdaq
  • Market Cap
  • CGEM 955.5M
  • BELFB 971.6M
  • IPO Year
  • CGEM 2021
  • BELFB N/A
  • Fundamental
  • Price
  • CGEM $16.02
  • BELFB $81.78
  • Analyst Decision
  • CGEM Strong Buy
  • BELFB Strong Buy
  • Analyst Count
  • CGEM 7
  • BELFB 2
  • Target Price
  • CGEM $31.67
  • BELFB $87.00
  • AVG Volume (30 Days)
  • CGEM 394.9K
  • BELFB 82.6K
  • Earning Date
  • CGEM 11-07-2024
  • BELFB 10-23-2024
  • Dividend Yield
  • CGEM N/A
  • BELFB 0.34%
  • EPS Growth
  • CGEM N/A
  • BELFB N/A
  • EPS
  • CGEM N/A
  • BELFB 4.32
  • Revenue
  • CGEM N/A
  • BELFB $524,943,000.00
  • Revenue This Year
  • CGEM N/A
  • BELFB N/A
  • Revenue Next Year
  • CGEM N/A
  • BELFB $10.23
  • P/E Ratio
  • CGEM N/A
  • BELFB $19.55
  • Revenue Growth
  • CGEM N/A
  • BELFB N/A
  • 52 Week Low
  • CGEM $7.64
  • BELFB $45.75
  • 52 Week High
  • CGEM $30.19
  • BELFB $85.91
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 47.61
  • BELFB 59.22
  • Support Level
  • CGEM $15.37
  • BELFB $73.50
  • Resistance Level
  • CGEM $17.19
  • BELFB $82.95
  • Average True Range (ATR)
  • CGEM 0.81
  • BELFB 2.69
  • MACD
  • CGEM 0.02
  • BELFB 0.00
  • Stochastic Oscillator
  • CGEM 42.79
  • BELFB 80.62

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

Share on Social Networks: